Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box–Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route

    October 2023 in “ Pharmaceutics
    Marwa H. Abdallah, Hemat El‐Sayed El‐Horany, Hanan M. El-Nahas, Tarek Ibrahim
    Studysummary This study found that an intranasal gel containing risperidone-loaded glycethosomes significantly enhanced drug bioavailability and improved neuroprotective, antioxidant, and anti-inflammatory effects in schizophrenia-induced rats compared to oral therapies, suggesting a promising alternative for schizophrenic patients who struggle with adhering to oral medication.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Enhanced Skin Penetration of Finasteride Loaded DMSO-Liposomes for the Treatment of Androgenic Alopecia: Comparison with Conventional Liposomes Drug Development and Industrial Pharmacy · 2023